Skip to main content
. 2022 Oct 28;5(10):e2238941. doi: 10.1001/jamanetworkopen.2022.38941

Figure 2. Prevalence of Risk for Neurodevelopmental Impairment (NDI) Among Infants Screened During the Pandemic, In Utero SARS-CoV-2–Exposed Cohort, and In Utero SARS-CoV-2–Unexposed Cohort.

Figure 2.

Analyses used a random-effects DerSimonian Laird model.